Study of Psychological and Sociological Predisposing the Development of Chronic Pain After Surgery in Women With Resectable Breast Cancer
Study of Psychological and Sociological Predisposing the Development of Chronic Pain After Surgery in Women With Resectable Breast Cancer
Certain psychological and social factors may increase the risk of developing chronic pain after surgery. Evaluating these factors over time in patients who have undergone surgery for breast cancer may help doctors plan treatment and improve patients' quality of life.
This clinical trial is studying the psychological and social factors that may increase the risk of developing chronic pain after surgery in women with breast cancer .
OBJECTIVES:
Primary : Determine the psychological and sociological factors that predispose post-mastectomy pain syndrome after surgery in women with resectable breast cancer.
Secondary
This is a multicenter study. Patients complete multiple questionnaires, including Hospital Anxiety and Depression Scale (HAD), Maudsley Personality Inventory (MPI), PCS, and QLQ-C30, to evaluate psychological variables (alexithymia, neurosis, repression of negative emotions, solicitude, dramatization, emotional distress) and quality of life.
Post-mastectomy chronic pain (PMCP) syndrome is measured immediately after surgery and at 24 hours, day 6, and 5 months post-surgery.
A subgroup of patients (20 with PMCP and 20 without PMCP) are followed at months 5 and 6 months post-surgery for medication use, pathological problems, morbid events, family history, and environmental factors.
DISEASE CHARACTERISTICS:
Diagnosis of breast cancer
Mastectomy or lumpectomy, including axillary lymph node dissection, planned
Analgesic fixed (or ordered) the morning of surgery
Hormone receptor status not specified
PATIENT CHARACTERISTICS:
Female
Menopausal status not specified
WHO performance status 0-2
Other prior malignancy allowed
No American Society of Anesthesiologists' class IV
No contraindication or drug addiction
No uncontrolled conditions, including any of the following:
PRIOR CONCURRENT THERAPY: